{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:19:12Z","timestamp":1782191952586,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010448","name":"Cl\u00ednica Las Condes","doi-asserted-by":"publisher","award":["2014-002"],"award-info":[{"award-number":["2014-002"]}],"id":[{"id":"10.13039\/100010448","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FONDECYT","award":["1151383"],"award-info":[{"award-number":["1151383"]}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.nmd.2020.03.008","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:42:26Z","timestamp":1590147746000},"page":"503-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy"],"prefix":"10.1016","volume":"30","author":[{"given":"Bernardita","family":"Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera","family":"Jofr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Lozano-Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-8547","authenticated-orcid":false,"given":"Jorge","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1981-7550","authenticated-orcid":false,"given":"Claudia","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2020.03.008_bib0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2020.03.008_bib0002","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.nmd.2020.03.008_bib0003","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti HMGCR autoantibodies in european patients with autoimmune necrotizing myopathies","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.nmd.2020.03.008_bib0004","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.nmd.2020.03.008_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000172","article-title":"Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease","volume":"2","author":"Mammen","year":"2015","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"issue":"4","key":"10.1016\/j.nmd.2020.03.008_bib0006","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","article-title":"Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology","volume":"2","author":"Alshehri","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"9","key":"10.1016\/j.nmd.2020.03.008_bib0007","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian","year":"2015","journal-title":"JAMA Neurol"},{"issue":"17","key":"10.1016\/j.nmd.2020.03.008_bib0008","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nmd.2020.03.008_bib0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","article-title":"Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies","volume":"56","author":"Liang","year":"2017","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.nmd.2020.03.008_bib0010","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3899\/jrheum.160871","article-title":"Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients","volume":"44","author":"Tansley","year":"2017","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.nmd.2020.03.008_bib0011","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/mus.25567","article-title":"Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child","volume":"56","author":"Mohassel","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.03.008_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2017.07.011","article-title":"Detection of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme a reductase by ELISA in a reference laboratory setting","volume":"472","author":"Jaskowski","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.nmd.2020.03.008_bib0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.1016\/j.nmd.2020.03.008_bib0014","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis C","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nmd.2020.03.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2019.03.005","article-title":"Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients","author":"Kang","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.nmd.2020.03.008_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pediatrneurol.2008.11.014","article-title":"Long remission in muscle-specific kinase antibody-positive juvenile myasthenia","volume":"40","author":"Anlar","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2020.03.008_bib0017","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jnnp.2007.134676","article-title":"Spontaneous recovery of dermatomyositis and unspecified myositis in three adult patients","volume":"79","author":"Van De Vlekkert","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.nmd.2020.03.008_bib0018","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.nmd.2004.09.003","article-title":"A case of severe congenital chronic inflammatory demyelinating polyneuropathy with complete spontaneous remission","volume":"14","author":"Majumdar","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2020.03.008_bib0019","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/acr.23113","article-title":"Association of anti\u20133-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1\u00d707:01 and severe myositis in juvenile myositis patients","volume":"69","author":"Kishi","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.nmd.2020.03.008_bib0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1604402","article-title":"Anti-HMGCR antibody-related necrotizing autoimmune myopathy mimicking muscular dystrophy","volume":"48","author":"Tard","year":"2017","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.nmd.2020.03.008_bib0021","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nmd.2019.05.007","article-title":"Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: possible double trouble","volume":"29","author":"Tanboon","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.03.008_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2018.08.010","article-title":"Statin-na\u00efve anti-HMGCR antibody-mediated necrotizing myopathy in China","volume":"57","author":"Jiao","year":"2018","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.nmd.2020.03.008_bib0023","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2019","journal-title":"Neurol \u2013 Neuroimmunol Neuroinflammation"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:05Z","timestamp":1760774945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620300870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0960896620300870"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.03.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}